Use of dienogest in endometriosis. A narrative literature review and expert commentary

Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature r...

Full description

Bibliographic Details
Main Authors: Ally Murji, Kutay Biberoğlu, Jinhua Leng
Format: Article
Language:English
Published: Publishing House TRILIST 2020-05-01
Series:Репродуктивная эндокринология
Subjects:
Online Access:http://reproduct-endo.com/article/view/202609
id doaj-beb9cd2cd02644de91d08fd4598a1cf5
record_format Article
spelling doaj-beb9cd2cd02644de91d08fd4598a1cf52021-07-02T10:47:24ZengPublishing House TRILISTРепродуктивная эндокринология2309-41172411-12952020-05-01052738110.18370/2309-4117.2020.52.73-81202609Use of dienogest in endometriosis. A narrative literature review and expert commentaryAlly Murji0Kutay Biberoğlu1Jinhua Leng2Mount Sinai Hospital, University of TorontoAnkara Private IVF CenterPeking Union Medical College HospitalObjective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature review, with recommendations on the use of dienogest in the context of various clinical considerations when treating endometriosis. Methods: A search of PubMed was conducted for papers published between 2007 and 2019 on the use of dienogest in endometriosis. Experts reviewed these and included those they considered most relevant in clinical practice, according to their own clinical experience. Results: Evidence regarding the long-term use (>15 months) of dienogest for the management of endometriosis is presented, with experts concluding that the efficacy of dienogest should be assessed primarily on its impact on pain and quality of life. Fertility preservation, the option to avoid or delay surgery, and managing bleeding irregularities that can occur with this treatment are also considered. Counseling women on potential bleeding risks before starting treatment may be helpful, and evidence suggests that few women discontinue treatment for this reason, with the benefits of treatment outweighing any impact of bleeding irregularities. Conclusions: Overall, the evidence demonstrates that dienogest offers an effective and tolerable alternative or adjunct to surgery and provides many advantages over combined hormonal contraceptives for the treatment of endometriosis. It is important that treatment guidelines are followed and care is tailored to the woman’s individual needs and desires.http://reproduct-endo.com/article/view/202609endometriosishormoneprogestinexpertsreview
collection DOAJ
language English
format Article
sources DOAJ
author Ally Murji
Kutay Biberoğlu
Jinhua Leng
spellingShingle Ally Murji
Kutay Biberoğlu
Jinhua Leng
Use of dienogest in endometriosis. A narrative literature review and expert commentary
Репродуктивная эндокринология
endometriosis
hormone
progestin
experts
review
author_facet Ally Murji
Kutay Biberoğlu
Jinhua Leng
author_sort Ally Murji
title Use of dienogest in endometriosis. A narrative literature review and expert commentary
title_short Use of dienogest in endometriosis. A narrative literature review and expert commentary
title_full Use of dienogest in endometriosis. A narrative literature review and expert commentary
title_fullStr Use of dienogest in endometriosis. A narrative literature review and expert commentary
title_full_unstemmed Use of dienogest in endometriosis. A narrative literature review and expert commentary
title_sort use of dienogest in endometriosis. a narrative literature review and expert commentary
publisher Publishing House TRILIST
series Репродуктивная эндокринология
issn 2309-4117
2411-1295
publishDate 2020-05-01
description Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature review, with recommendations on the use of dienogest in the context of various clinical considerations when treating endometriosis. Methods: A search of PubMed was conducted for papers published between 2007 and 2019 on the use of dienogest in endometriosis. Experts reviewed these and included those they considered most relevant in clinical practice, according to their own clinical experience. Results: Evidence regarding the long-term use (>15 months) of dienogest for the management of endometriosis is presented, with experts concluding that the efficacy of dienogest should be assessed primarily on its impact on pain and quality of life. Fertility preservation, the option to avoid or delay surgery, and managing bleeding irregularities that can occur with this treatment are also considered. Counseling women on potential bleeding risks before starting treatment may be helpful, and evidence suggests that few women discontinue treatment for this reason, with the benefits of treatment outweighing any impact of bleeding irregularities. Conclusions: Overall, the evidence demonstrates that dienogest offers an effective and tolerable alternative or adjunct to surgery and provides many advantages over combined hormonal contraceptives for the treatment of endometriosis. It is important that treatment guidelines are followed and care is tailored to the woman’s individual needs and desires.
topic endometriosis
hormone
progestin
experts
review
url http://reproduct-endo.com/article/view/202609
work_keys_str_mv AT allymurji useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary
AT kutaybiberoglu useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary
AT jinhualeng useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary
_version_ 1721331715776970752